IQVIA slides after Q4 results as earnings outlook underwhelms
Source: SeekingAlpha
2026-02-05 10:49:39 ET
More on IQVIA
- IQVIA: Increasingly Indispensable In Drug Development
- IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript
- IQVIA Q4 2025 Earnings Preview
- CROs fall as FDA head Makary says drug approvals will require fewer trials
- Seeking Alpha’s Quant Rating on IQVIA
Read the full article on Seeking Alpha
For further details see:
IQVIA slides after Q4 results as earnings outlook underwhelms
Medpace Holdings Inc.
NASDAQ: MEDP
MEDP Trading
-0.75% G/L:
$450.99 Last:
111,208 Volume:
$450.52 Open:
MEDP Latest News
February 23, 2026 12:10:00 am
Ongoing Investigation: Medpace Holdings, Inc. (MEDP) May Have Misled Shareholders - Levi & Korsinsky Investigates
February 18, 2026 09:00:00 am
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
February 16, 2026 01:50:00 pm
Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness
MEDP Stock Data
$12,487,114,097
22,450,074
3.25%
359
N/A
Biotechnology & Life Sciences
Healthcare
US
Cincinnati
